Mendelspod PodcastLong DNA for Difficult Applications: Dan Lin-Arlow, CEO, Ansa Biotech 811×Preview0:00Current time: 0:00 / Total time: -8:12-8:12Audio playback is not supported on your browser. Please upgrade.Long DNA for Difficult Applications: Dan Lin-Arlow, CEO, Ansa Biotech Theral TimpsonSep 13, 2023∙ Paid81ShareChapters:0:00 World’s longest oligo8:45 Why is it difficult to synthesize long DNA?12:00 Proprietary TdT conjugate16:00 A billion-dollar market24:20 The computation model and its challenges28:35 More customers using generative AIMendelspod is now reader supported. Please consider upgrading to a paid subscription for the price of a couple cof…SubscribeThis post is for paid subscribersSubscribeAlready a paid subscriber? Sign inMendelspod PodcastOffering a front row seat to the Century of Biology, veteran podcast host Theral Timpson interviews the who's who in genomics and genomic medicine.Offering a front row seat to the Century of Biology, veteran podcast host Theral Timpson interviews the who's who in genomics and genomic medicine.SubscribeListen onSubstack AppRSS FeedAppears in episodeTheral TimpsonRecent EpisodesMyriad’s Next Chapter: New CEO Sam Raha on Growth, AI, and MRD Testing2 mins ago • Theral TimpsonNext-Gen MRD Testing: Foresight’s Leap in Sensitivity with Jake Chabon and Dave KurtzSep 11 • Theral TimpsonBodour Salhia and Danielle Goldberg: Rethinking Cancer Research with Illumina's 5-Base SolutionSep 9 • Theral TimpsonReinventing PCR: Pranav Patel, N6 TecSep 2 • Theral TimpsonMaking Whole Genome Sequencing the Universal Genetic Test - with David Ledbetter, Pediatric Rare Disease Institute, FSUAug 28 • Theral TimpsonRemembering Atul Butte with Marina Sirota, Chirag Patel and Mike SnyderAug 21 • Theral TimpsonThe Age of Digital Pathology with Andy Beck, PathAIAug 14 • Theral TimpsonWhat’s New for Regulatory Informatics in the Age of AI? Not Much—And That’s the Point with Raju Rayavarapu of DNAnexusAug 5 • Theral Timpson